Blackstone and Boston Scientific Sign $455 Million Heart-Pump Deal
Blackstone Life Sciences and Boston Scientific will co-fund development of Vitalyst, a minimally invasive heart pump designed to support heart pumping without open-heart surgery.
By Katherine HamiltonBlackstone Life Sciences signed a $455 million deal with Boston Scientific to co-fund the development of a minimally invasive heart pump.The two companies are developing Vitalyst, a Boston Scientific device designed to support heart pumping without open-heart surgery.The Vitaly…